• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Personalized Medicine in Europe.欧洲的个性化医疗。
Clin Transl Sci. 2017 Mar;10(2):61-63. doi: 10.1111/cts.12446. Epub 2017 Mar 3.
2
Translating personalized genomic medicine into clinical practice: evidence, values, and health policy.将个性化基因组医学转化为临床实践：证据、价值观与卫生政策。
Genome. 2015 Dec;58(12):491-7. doi: 10.1139/gen-2015-0145. Epub 2015 Nov 18.
3
H2020 and Beyond: Skip Discrepancy between Theory and Practice of Personalized Medicine. A Position Paper by the Italian Society of Personalized Medicine.“地平线2020”及未来：弥合精准医学理论与实践之间的差距。意大利精准医学学会立场文件
Curr Pharm Biotechnol. 2016;17(10):926-9. doi: 10.2174/1389201017666160519112850.
4
The current status and problems confronted in delivering precision medicine in Japan and Europe.日本和欧洲在提供精准医疗方面面临的现状与问题。
Curr Probl Cancer. 2017 May-Jun;41(3):166-175. doi: 10.1016/j.currproblcancer.2017.02.003. Epub 2017 Feb 22.
5
Enabling personalized medicine in Europe by the European Commission's funding activities.通过欧盟委员会的资助活动在欧洲推动个性化医疗。
Per Med. 2017 Jul;14(4):355-365. doi: 10.2217/pme-2017-0003. Epub 2017 Jun 23.
6
The Amsterdam Treaty and the future of European health services.
J Health Serv Res Policy. 1998 Apr;3(2):65-7. doi: 10.1177/135581969800300201.
7
US Cancer Moonshot must strike a balance between research and prevention.美国癌症“登月计划”必须在研究与预防之间找到平衡。
Nature. 2016 Nov 24;539(7630):467. doi: 10.1038/539467a.
8
Chemistry and personalized medicine - the research and development future of Europe.化学与个性化医疗——欧洲的研发未来
Croat Med J. 2012 Aug;53(4):291-3. doi: 10.3325/cmj.2012.53.291.
9
Proceedings: international regulatory considerations on development pathways for cell therapies.会议记录：细胞疗法开发途径的国际监管考量
Stem Cells Transl Med. 2014 Aug;3(8):879-87. doi: 10.5966/sctm.2014-0122. Epub 2014 Jul 18.
10
Introduction: Comparative health law and policy: what, if anything, can we learn from other countries?引言：比较卫生法与政策：我们能从其他国家学到什么（如果有的话）？
J Law Med Ethics. 2009 Winter;37(4):790-1. doi: 10.1111/j.1748-720X.2009.00449.x.

引用本文的文献

1
Bridging the Divide: A Review on the Implementation of Personalized Cancer Medicine.弥合差距：个性化癌症医学实施综述
J Pers Med. 2024 May 24;14(6):561. doi: 10.3390/jpm14060561.
2
Intelligent Liver Function Testing (iLFT): An Intelligent Laboratory Approach to Identifying Chronic Liver Disease.智能肝功能检测（iLFT）：一种识别慢性肝病的智能实验室方法。
Diagnostics (Basel). 2024 May 4;14(9):960. doi: 10.3390/diagnostics14090960.
3
Preventing Bone Loss in Breast Cancer Patients: Designing a Personalized Clinical Pathway in a Large-Volume Research Hospital.预防乳腺癌患者骨质流失：在一家大型研究医院设计个性化临床路径
J Pers Med. 2024 Mar 30;14(4):371. doi: 10.3390/jpm14040371.
4
Advancing Precision Medicine: A Review of Innovative In Silico Approaches for Drug Development, Clinical Pharmacology and Personalized Healthcare.推进精准医学：药物研发、临床药理学和个性化医疗中创新的计算机模拟方法综述。
Pharmaceutics. 2024 Feb 27;16(3):332. doi: 10.3390/pharmaceutics16030332.
5
Toward a global harmonization of service infrastructure in academic clinical trial units: an international survey.迈向学术临床试验单位服务基础设施的全球协调：一项国际调查。
Front Med (Lausanne). 2023 Oct 12;10:1252352. doi: 10.3389/fmed.2023.1252352. eCollection 2023.
6
3D Printing Technologies in Personalized Medicine, Nanomedicines, and Biopharmaceuticals.个性化医疗、纳米药物和生物制药中的3D打印技术
Pharmaceutics. 2023 Jan 17;15(2):313. doi: 10.3390/pharmaceutics15020313.
7
An overview of Personalized Medicine landscape and policies in the European Union.欧盟个性化医学的现状与政策概述。
Eur J Public Health. 2022 Nov 29;32(6):844-851. doi: 10.1093/eurpub/ckac103.
8
The Contribution of Clinical Pharmacologists in Precision Medicine: An Opportunity for Health Care Improvement.临床药理学家在精准医学中的贡献：改善医疗保健的契机。
Curr Ther Res Clin Exp. 2021 Apr 1;94:100628. doi: 10.1016/j.curtheres.2021.100628. eCollection 2021.
9
Personalized Clinical Phenotyping through Systems Medicine and Artificial Intelligence.通过系统医学和人工智能实现个性化临床表型分析
J Pers Med. 2021 Apr 2;11(4):265. doi: 10.3390/jpm11040265.
10
Pharmacogenomics of oxycodone: a narrative literature review.羟考酮的药物基因组学：叙事文献综述。
Pharmacogenomics. 2021 Apr;22(5):275-290. doi: 10.2217/pgs-2020-0143. Epub 2021 Mar 17.

本文引用的文献

1
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients.药物不良反应作为入院原因：对18820例患者的前瞻性分析。
BMJ. 2004 Jul 3;329(7456):15-9. doi: 10.1136/bmj.329.7456.15.

Personalized Medicine in Europe.

作者信息

Nimmesgern E, Benediktsson I, Norstedt I

机构信息

European Commission, Innovative and Personalised Medicine Unit, Health Directorate, Directorate-General Research and Innovation, B-1049, Brussels, Belgium.

出版信息

Clin Transl Sci. 2017 Mar;10(2):61-63. doi: 10.1111/cts.12446. Epub 2017 Mar 3.

DOI:10.1111/cts.12446
PMID:28083940
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5355974/
Abstract
摘要